Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:MODD NASDAQ:NEPH NASDAQ:PAVM NASDAQ:POCI On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeMODDModular Medical$0.69-0.3%$0.81$0.63▼$2.65$37.45M0.17223,569 shs74,054 shsNEPHNephros$3.64+1.7%$3.40$1.36▼$5.00$38.64M1.0918,636 shs21,142 shsPAVMPAVmed$0.60+0.6%$0.62$0.54▼$1.90$10.31M1.06136,593 shs87,729 shsPOCIPrecision Optics$4.79-0.5%$4.67$3.47▼$6.59$36.49M0.2516,176 shs7,294 shsA Beginner's Guide to Investing in CannabisUnlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceMODDModular Medical0.00%-2.82%-14.39%-22.30%-55.77%NEPHNephros0.00%+1.11%+1.68%+85.81%+68.52%PAVMPAVmed0.00%+1.00%-1.10%-15.03%-47.77%POCIPrecision Optics0.00%-2.35%+4.70%+20.99%-20.25%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationMODDModular MedicalN/AN/AN/AN/AN/AN/AN/AN/ANEPHNephros2.1748 of 5 stars3.55.00.00.00.60.80.0PAVMPAVmed3.9758 of 5 stars3.53.00.04.30.00.01.9POCIPrecision OpticsN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceMODDModular Medical 0.00N/AN/AN/ANEPHNephros 3.00Buy$5.0037.36% UpsidePAVMPAVmed 3.00Buy$19.003,049.35% UpsidePOCIPrecision Optics 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest PAVM, NEPH, MODD, and POCI Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/6/2025PAVMPAVmedAscendiant Capital MarketsSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$19.50 ➝ $19.004/21/2025PAVMPAVmedAscendiant Capital MarketsSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$19.00 ➝ $19.50(Data available from 7/20/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookMODDModular MedicalN/AN/AN/AN/A$0.42 per shareN/ANEPHNephros$14.16M2.72$0.02 per share182.15$0.81 per share4.49PAVMPAVmed$2.99M3.45N/AN/A($0.92) per share-0.66POCIPrecision Optics$19.10M1.92N/AN/A$1.66 per share2.88Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateMODDModular Medical-$18.82M-$0.51N/A∞N/AN/A-178.13%-151.42%8/12/2025 (Estimated)NEPHNephros$70K$0.0752.01∞N/A5.16%9.43%7.20%8/6/2025 (Estimated)PAVMPAVmed$39.79M$0.710.85N/AN/A3,711.54%N/A-42.29%8/12/2025 (Estimated)POCIPrecision Optics-$2.95M-$0.89N/A∞N/A-32.84%-54.03%-32.48%9/29/2025 (Estimated)Latest PAVM, NEPH, MODD, and POCI EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/12/2025Q2 2025PAVMPAVmed-$0.25N/AN/AN/A$0.01 millionN/A6/20/2025Q4 2025MODDModular Medical-$0.11-$0.12-$0.01-$0.12N/AN/A5/15/2025Q1 2025NEPHNephros-$0.0050$0.0526+$0.0576$0.05$3.67 million$4.88 million5/15/2025Q3 2025POCIPrecision OpticsN/A-$0.30N/A-$0.30N/A$4.19 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthMODDModular MedicalN/AN/AN/AN/AN/ANEPHNephrosN/AN/AN/AN/AN/APAVMPAVmedN/AN/AN/AN/AN/APOCIPrecision OpticsN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioMODDModular MedicalN/A10.6910.69NEPHNephrosN/A5.924.64PAVMPAVmedN/A0.370.37POCIPrecision Optics0.111.991.26Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipMODDModular Medical27.47%NEPHNephros41.10%PAVMPAVmed19.93%POCIPrecision Optics13.71%Insider OwnershipCompanyInsider OwnershipMODDModular Medical20.46%NEPHNephros6.70%PAVMPAVmed7.30%POCIPrecision Optics12.99%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableMODDModular Medical2054.25 million43.15 millionNot OptionableNEPHNephros3010.60 million9.89 millionNot OptionablePAVMPAVmed9017.09 million15.85 millionOptionablePOCIPrecision Optics807.67 million6.67 millionNot OptionablePAVM, NEPH, MODD, and POCI HeadlinesRecent News About These CompaniesPrecision Optics Corporation Inc News (POCI) - Investing.comJune 26, 2025 | investing.comLaCroix Precision Optics Expands in Batesville, Arkansas, Creating 107 New JobsJune 5, 2025 | globenewswire.comPrecision Optics Expands Facilities to Meet Growing BacklogJune 5, 2025 | globenewswire.comPrecision Optics to Participate in the Lytham Partners Spring 2025 Investor Conference on May 29, 2025May 27, 2025 | globenewswire.comPrecision Optics reports annual meeting resultsMay 25, 2025 | investing.comPrecision Optics Corporation: Precision Optics Reports Third Quarter Fiscal Year 2025 Financial ResultsMay 16, 2025 | finanznachrichten.dePrecision Optics Corporation, Inc. (POCI) Q1 2025 Earnings Conference Call TranscriptMay 15, 2025 | seekingalpha.comPrecision Optics Reports Third Quarter Fiscal Year 2025 Financial ResultsMay 15, 2025 | globenewswire.comPrecision Optics Market Global Forecast Report to 2030: Cumulative Impact of United States TariffsMay 14, 2025 | globenewswire.comPrecision Optics Schedules Third Quarter of Fiscal Year 2025 Conference Call for May 15, 2025May 8, 2025 | globenewswire.comPrecision Optics to Present at the Planet MicroCap Showcase: VEGAS 2025 on April 23, 2025April 21, 2025 | globenewswire.comPrecision Optics Signs Major Aerospace Deal, Expands Backlog To $6.6M With New OrdersApril 5, 2025 | nasdaq.comPrecision Optics enters into main purchase agreement with aerospace customerApril 4, 2025 | markets.businessinsider.comPrecision Optics to Participate in the Lytham [...]March 27, 2025 | aktiencheck.deAPrecision Optics to Participate in the Lytham Partners 2025 Industrials & Basic Materials Investor Summit on April 1, 2025March 27, 2025 | globenewswire.comPrecision Optics Appoints Joseph P. Pellegrino, Jr. to Board of DirectorsMarch 20, 2025 | globenewswire.comPrecision Optics Appoints Buell Duncan to Board of Directors; Dr. Richard Miles Retires from BoardMarch 4, 2025 | globenewswire.comPrecision Optics Announces Closing of $5.1 Million Offering of Common Stock to Fund Business ExpansionFebruary 24, 2025 | globenewswire.comPrecision Optics prices 1.27M shares at $4.00 in registered direct offeringFebruary 20, 2025 | markets.businessinsider.comPrecision Optics Announces Pricing of $5.1 Million Offering of Common Stock to Fund Business ExpansionFebruary 20, 2025 | finance.yahoo.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimePAVM, NEPH, MODD, and POCI Company DescriptionsModular Medical NASDAQ:MODD$0.69 0.00 (-0.29%) Closing price 07/18/2025 04:00 PM EasternExtended Trading$0.70 +0.02 (+2.17%) As of 07/18/2025 06:21 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Modular Medical, Inc. operates as a medical device company. It focuses on the design, development, and commercialization of insulin pumps. It offers MODD1, a two-part patch pump for type-1 and type-2 diabetes. The company is headquartered in San Diego, California.Nephros NASDAQ:NEPH$3.64 +0.06 (+1.68%) Closing price 07/18/2025 03:52 PM EasternExtended Trading$3.64 +0.00 (+0.14%) As of 07/18/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Nephros, Inc., a commercial-stage company, develops and sells water solutions to the medical and commercial markets in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities. The company also manufactures and sells water filters that enhance the taste and odor of water, as well as reduce biofilm, cysts, particulates, and scale build-up in downstream equipment. It markets its products to food service, hospitality, convenience store, and health care markets, as well as medical institutions. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey.PAVmed NASDAQ:PAVM$0.60 +0.00 (+0.55%) Closing price 07/18/2025 04:00 PM EasternExtended Trading$0.60 +0.00 (+0.28%) As of 07/18/2025 07:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.PAVmed Inc. focuses on acquiring, developing, and commercializing novel products that target unmet needs in the United States. The company's lead products include CarpX, a patented, single-use, disposable, and minimally invasive surgical device for use in the treatment of carpal tunnel syndrome; EsoCheck Esophageal Cell Collection Device, which consists of diagnostic test that serves as a testing tool for preventing esophageal adenocarcinoma deaths, through early detection of esophageal precancer in at-risk gastroesophageal reflux disease, including chronic heartburn and acid reflux or simply reflux in patients; and EsoGuard, a bisulfite-converted next-generation sequencing DNA assay performed on surface esophageal cells collected with EsoCheck. Its product pipeline also comprises EsoCure EsoCure Esophageal Ablation Device for treating dysplastic BE; PortIO, an implantable intraosseous vascular access device; and Veris cancer care platform. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was incorporated in 2014 and is headquartered in New York, New York.Precision Optics NASDAQ:POCI$4.78 -0.03 (-0.52%) Closing price 07/18/2025 03:57 PM EasternExtended Trading$5.01 +0.23 (+4.70%) As of 07/18/2025 04:37 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Precision Optics Corporation, Inc. designs, develops, manufactures, and sells specialized optical and illumination systems and related components primarily in the United States and the European Economic Area. It offers medical instrumentation products, including endoscopes and endocouplers, as well as other custom imaging and illumination products, such as Microprecision lenses and micro medical cameras, and 3D endoscopes for use in minimally invasive surgical procedures by hospitals and physicians. The company also provides components and assemblies for industrial and military use. It markets its products to medical device companies. The company was incorporated in 1982 and is based in Gardner, Massachusetts. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 07/14 - 07/18 Netflix Q2 2025 Earnings: What Investors Need to Know High-Flying GE Aerospace Drops After Blowout Q2 — What Now? A New $70 Billion AI Investment Could Push Taiwan Semiconductor Why Prologis May Be the Smartest Backdoor Bet on AI Real Estate Snap-On: Snap Up This Strong Signal While It’s Still Cheap Why Abbott Laboratories Is a Q2 2025 Buy: Growth & Yield Why Pure Storage Is a Core Investment for the AI Era Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
